Stress in the metastatic journey - the role of cell communication and clustering in breast cancer progression and treatment resistance
- PMID: 38506114
- PMCID: PMC10979546
- DOI: 10.1242/dmm.050542
Stress in the metastatic journey - the role of cell communication and clustering in breast cancer progression and treatment resistance
Abstract
Breast cancer stands as the most prevalent malignancy afflicting women. Despite significant advancements in its diagnosis and treatment, breast cancer metastasis continues to be a leading cause of mortality among women. To metastasize, cancer cells face numerous challenges: breaking away from the primary tumor, surviving in the circulation, establishing in a distant location, evading immune detection and, finally, thriving to initiate a new tumor. Each of these sequential steps requires cancer cells to adapt to a myriad of stressors and develop survival mechanisms. In addition, most patients with breast cancer undergo surgical removal of their primary tumor and have various therapeutic interventions designed to eradicate cancer cells. Despite this plethora of attacks and stresses, certain cancer cells not only manage to persist but also proliferate robustly, giving rise to substantial tumors that frequently culminate in the patient's demise. To enhance patient outcomes, there is an imperative need for a deeper understanding of the molecular and cellular mechanisms that empower cancer cells to not only survive but also expand. Herein, we delve into the intrinsic stresses that cancer cells encounter throughout the metastatic journey and the additional stresses induced by therapeutic interventions. We focus on elucidating the remarkable strategies adopted by cancer cells, such as cell-cell clustering and intricate cell-cell communication mechanisms, to ensure their survival.
Keywords: Breast cancer; Cluster; Metastasis; Stress.
© 2024. Published by The Company of Biologists Ltd.
Conflict of interest statement
Competing interests The authors declare no competing or financial interests.
Figures
![Fig. 1.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10979546/bin/dmm-17-050542-g1.gif)
![Fig. 2.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10979546/bin/dmm-17-050542-g2.gif)
![Fig. 3.](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/10979546/bin/dmm-17-050542-g3.gif)
Similar articles
-
Cellular dormancy in minimal residual disease following targeted therapy.Breast Cancer Res. 2021 Jun 4;23(1):63. doi: 10.1186/s13058-021-01416-9. Breast Cancer Res. 2021. PMID: 34088357 Free PMC article.
-
Stresses in the metastatic cascade: molecular mechanisms and therapeutic opportunities.Genes Dev. 2020 Dec 1;34(23-24):1577-1598. doi: 10.1101/gad.343251.120. Genes Dev. 2020. PMID: 33262145 Free PMC article. Review.
-
Nanoparticle Delivery of TWIST Small Interfering RNA and Anticancer Drugs: A Therapeutic Approach for Combating Cancer.Enzymes. 2018;44:83-101. doi: 10.1016/bs.enz.2018.08.004. Epub 2018 Oct 5. Enzymes. 2018. PMID: 30360816 Review.
-
Microenvironmental Influences on Metastasis Suppressor Expression and Function during a Metastatic Cell's Journey.Cancer Microenviron. 2014 Dec;7(3):117-31. doi: 10.1007/s12307-014-0148-4. Epub 2014 Jun 18. Cancer Microenviron. 2014. PMID: 24938990 Free PMC article.
-
Overview of resistance to systemic therapy in patients with breast cancer.Adv Exp Med Biol. 2007;608:1-22. doi: 10.1007/978-0-387-74039-3_1. Adv Exp Med Biol. 2007. PMID: 17993229 Review.
References
-
- Aceto, N., Bardia, A., Miyamoto, D. T., Donaldson, M. C., Wittner, B. S., Spencer, J. A., Yu, M., Pely, A., Engstrom, A., Zhu, H.et al. (2014). Circulating tumor cell clusters are oligoclonal precursors of breast cancer metastasis. Cell 158, 1110-1122. 10.1016/j.cell.2014.07.013 - DOI - PMC - PubMed
-
- Albrengues, J., Bertero, T., Grasset, E., Bonan, S., Maiel, M., Bourget, I., Philippe, C., Herraiz Serrano, C., Benamar, S., Croce, O.et al. (2015). Epigenetic switch drives the conversion of fibroblasts into proinvasive cancer-associated fibroblasts. Nat. Commun. 6, 10204. 10.1038/ncomms10204 - DOI - PMC - PubMed
-
- Albrengues, J., Shields, M. A., Ng, D., Park, C. G., Ambrico, A., Poindexter, M. E., Upadhyay, P., Uyeminami, D. L., Pommier, A., Küttner, V.et al. (2018). Neutrophil extracellular traps produced during inflammation awaken dormant cancer cells in mice. Science 361, eaao4227. 10.1126/science.aao4227 - DOI - PMC - PubMed
-
- Allen, T. A., Asad, D., Amu, E., Hensley, M. T., Cores, J., Vandergriff, A., Tang, J., Dinh, P.-U., Shen, D., Qiao, L.et al. (2019). Circulating tumor cells exit circulation while maintaining multicellularity, augmenting metastatic potential. J. Cell Sci. 132, jcs231563. 10.1242/jcs.231563 - DOI - PMC - PubMed
MeSH terms
Grants and funding
LinkOut - more resources
Full Text Sources
Medical